Aetion Launches FDA Decision Alerts

Aetion announced the launch of a new library of FDA submissions that used real-world data and real-world evidence, the FDA Decision Alerts.

“To enable our partners to learn from the growing empirical evidence base of regulatory decisions, Aetion is systematically assessing drug and biologic approval documents to understand when, where, and how RWE studies were included and used in applications,” Aetion said in an email.

To learn more about the library, click here.